Literature DB >> 27577250

Sentinel lymph node biopsy in early melanoma-comparison of two techniques for sentinel removal.

Uwe Wollina1, Dana Langner2, Jacqueline Schönlebe3, Carmen Tanner4, Martin Fuchs4, Andreas Nowak5.   

Abstract

BACKGROUND: Sentinel lymph node biopsy is an established technique for melanoma staging.
OBJECTIVE: There are no studies available comparing different techniques for the removal of sentinel lymph nodes related to safety and postsurgical complication rate.
METHODS: This is a retrospective single-center trial. We analyzed the postsurgical complications in 201 consecutive melanoma patients with ligature of lymphatic vessels by sutures (group A) and in 91 consecutive patients with occlusion of lymphatic vessels by bipolar tweezers (group B). We paid particular attention to complications related to disturbed lymphatic function, such as lymph edema, lymphatic fistula, and seroma.
RESULTS: The complication rate was 5.5 % (group A) and 9.6 % (group B) which is in the range of other published trials (p = 0.89). There was no increase of complications related to lymphatic vessels in group B, although the rate of patients with more than two sentinel lymph nodes removed was 5‑times higher than in group A.
CONCLUSIONS: Removal of sentinel lymph nodes with the use of bipolar tweezers does not increase the risk of postsurgical complications, and in particular it is not associated with a higher rate of complications related to lymphatic vessel dysfunction.

Entities:  

Keywords:  Lymph node excision; Lymphatic vessels; Malignant melanoma; Postsurgical complications; Sentinel lymph node biopsy

Mesh:

Year:  2016        PMID: 27577250     DOI: 10.1007/s10354-016-0499-1

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  18 in total

1.  Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands.

Authors:  Frank J van den Broek; Pim C Sloots; Jan-Willem D de Waard; Rudi M Roumen
Journal:  Int J Clin Oncol       Date:  2012-03-09       Impact factor: 3.402

2.  Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

Authors:  Annette Pflugfelder; Corinna Kochs; Andreas Blum; Marcus Capellaro; Christina Czeschik; Therese Dettenborn; Dorothee Dill; Edgar Dippel; Thomas Eigentler; Petra Feyer; Markus Follmann; Bernhard Frerich; Maria-Katharina Ganten; Jan Gärtner; Ralf Gutzmer; Jessica Hassel; Axel Hauschild; Peter Hohenberger; Jutta Hübner; Martin Kaatz; Ulrich R Kleeberg; Oliver Kölbl; Rolf-Dieter Kortmann; Albrecht Krause-Bergmann; Peter Kurschat; Ulrike Leiter; Hartmut Link; Carmen Loquai; Christoph Löser; Andreas Mackensen; Friedegund Meier; Peter Mohr; Matthias Möhrle; Dorothee Nashan; Sven Reske; Christian Rose; Christian Sander; Imke Satzger; Meinhard Schiller; Heinz-Peter Schlemmer; Gerhard Strittmatter; Cord Sunderkötter; Lothar Swoboda; Uwe Trefzer; Raymond Voltz; Dirk Vordermark; Michael Weichenthal; Andreas Werner; Simone Wesselmann; Ansgar J Weyergraf; Wolfgang Wick; Claus Garbe; Dirk Schadendorf
Journal:  J Dtsch Dermatol Ges       Date:  2013-08       Impact factor: 5.584

3.  Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experience.

Authors:  Milap G Rughani; Marc C Swan; Titus S Adams; Mark R Middleton; Roger N Ramcharan; Andy Pay; Jeremy F Birch; David J Coleman; Oliver C Cassell
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-05-25       Impact factor: 2.740

4.  Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.

Authors:  Augustinus P T van der Ploeg; Lauren E Haydu; Andrew J Spillane; Michael J Quinn; Robyn Pm Saw; Kerwin F Shannon; Jonathan R Stretch; Roger F Uren; Richard A Scolyer; John F Thompson
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

5.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

6.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

7.  A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up.

Authors:  Josefine Beger; Gesina Hansel; Claudia Krönert; Martin Fuchs; Carmen Tanner; Jaqueline Schönlebe; Carmen Werner; Andreas Nowak; Gunter Haroske; Helmut Witzigmann; Uwe Wollina
Journal:  Int J Dermatol       Date:  2013-02       Impact factor: 2.736

8.  Final version of 2009 AJCC melanoma staging and classification.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Sentinel lymph node biopsy for melanoma: comparison of lymphocele rates by surgical technique.

Authors:  Ian White; Jane K Mills; Brian Diggs; Jeanine Fortino Hima; Michelle C Ellis; John T Vetto
Journal:  Am Surg       Date:  2013-04       Impact factor: 0.688

10.  Melanoma computer-aided diagnosis: reliability and feasibility study.

Authors:  Marco Burroni; Rosamaria Corona; Giordana Dell'Eva; Francesco Sera; Riccardo Bono; Pietro Puddu; Roberto Perotti; Franco Nobile; Lucio Andreassi; Pietro Rubegni
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.